Tiedemann Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $295K | Buy |
4,045
+8
| +0.2% | +$584 | 0.01% | 223 |
|
|
2023
Q2 | $336K | Buy |
+4,037
| New | +$336K | 0.01% | 199 |
|
|
2022
Q2 | – | Sell |
-8,742
| Closed | -$786K | – | 303 |
|
|
2022
Q1 | $786K | Buy |
8,742
+868
| +11% | +$78K | 0.04% | 157 |
|
|
2021
Q4 | $882K | Buy |
7,874
+231
| +3% | +$25.9K | 0.04% | 154 |
|
|
2021
Q3 | $961K | Sell |
7,643
-776
| -9% | -$97.6K | 0.05% | 143 |
|
|
2021
Q2 | $1.14M | Hold |
8,419
| – | – | 0.05% | 161 |
|
|
2021
Q1 | $1.14M | Sell |
8,419
-4,034
| -32% | -$547K | 0.05% | 150 |
|
|
2020
Q4 | $1.76M | Buy |
12,453
+45
| +0.4% | +$6.34K | 0.08% | 109 |
|
|
2020
Q3 | $1.38M | Buy |
12,408
+175
| +1% | +$19.5K | 0.07% | 151 |
|
|
2020
Q2 | $1.37M | Sell |
12,233
-6,482
| -35% | -$725K | 0.07% | 141 |
|
|
2020
Q1 | $1.45M | Buy |
18,715
+11
| +0.1% | +$852 | 0.09% | 128 |
|
|
2019
Q4 | $1.78M | Sell |
18,704
-4,887
| -21% | -$465K | 0.09% | 121 |
|
|
2019
Q3 | $1.8M | Buy |
+23,591
| New | +$1.8M | 0.09% | 129 |
|
|
2019
Q2 | – | Sell |
-9,615
| Closed | -$870K | – | 430 |
|
|
2019
Q1 | $870K | Hold |
9,615
| – | – | 0.04% | 232 |
|
|
2018
Q4 | $690K | Buy |
+9,615
| New | +$690K | 0.04% | 251 |
|